Company Filing History:
Years Active: 1998-2011
Title: The Innovative Contributions of Andrew B. Kelson
Introduction
Andrew B. Kelson is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that aid in the treatment of cancer and autoimmune diseases. With a total of 3 patents, his work has garnered attention for its potential impact on medical therapies.
Latest Patents
Kelson's latest patents include two significant innovations. The first patent is for "2-{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidates and their salts, their preparation and intermediates in their preparation, pharmaceutical compositions containing them, and methods of treatment using them." This compound is particularly useful for treating cancer and autoimmune diseases, both alone and in combination with other therapies. The second patent focuses on "Tripeptide and tetrapeptide thioethers, pharmaceutical compositions containing them, their pharmaceutical use, and their preparation." These compounds are designed to enhance the cytotoxic effects of chemotherapeutic agents in tumor cells, selectively targeting tumor cells while also stimulating bone marrow functions.
Career Highlights
Throughout his career, Andrew B. Kelson has worked with several prominent companies, including Telik, Inc. and SRI International. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical research and development.
Collaborations
Kelson has collaborated with notable individuals in his field, including Michael Tracy and Paul Workman. These partnerships have likely facilitated the exchange of ideas and fostered innovation in their respective projects.
Conclusion
Andrew B. Kelson's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treatments for serious medical conditions.